Novocure
NVCR
#5712
Rank
NZ$2.40 B
Marketcap
Country
NZ$20.54
Share price
-4.48%
Change (1 day)
3.46%
Change (1 year)
Categories

Earnings for Novocure (NVCR)

Earnings in 2026 (TTM): -NZ$0.16 Billion

According to Novocure 's latest financial reports the company's current earnings are NZ$0.72 Billion. In 2025 the company made an earning of -NZ$0.22 Billion, an increase over its 2024 earnings that were of -NZ$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novocure from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.16 Billion-27.69%
2025 -NZ$0.22 Billion-1.33%
2024 -NZ$0.22 Billion-35.88%
2023 -NZ$0.35 Billion139.99%
2022 -NZ$0.15 Billion61.43%
2021 -NZ$88.42 Million-235.99%
2020 NZ$65.01 M630.75%
2019 NZ$8.89 M-115.08%
2018 -NZ$59 Million-15.13%
2017 -NZ$69.51 Million-66.9%
2016 -NZ$0.22 Billion10.26%
2015 -NZ$0.2 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Organovo
ONVO
-NZ$4.52 Million-97.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-NZ$0.14 Billion-18.78%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-NZ$0.41 Billion 148.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-NZ$0.17 Billion 0.00% Jersey